These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 32004772

  • 1. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers.
    Cestari RN, Caris JA, Rocha A, Nardotto GHB, de Oliveira RDR, Lanchote VL.
    J Pharm Biomed Anal; 2020 Apr 15; 182():113128. PubMed ID: 32004772
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: Application in a clinical pharmacokinetic study of single oral dose.
    Cestari RN, Rocha A, Marques MP, de Oliveira RDR, Lanchote VL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep 15; 1126-1127():121766. PubMed ID: 31450089
    [Abstract] [Full Text] [Related]

  • 3. Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics.
    Fauler G, Abletshauser C, Erwa W, Löser R, Witschital K, März W.
    Int J Clin Pharmacol Ther; 2007 Jun 15; 45(6):328-34. PubMed ID: 17595890
    [Abstract] [Full Text] [Related]

  • 4. Effects of Single Dose Rifampin on the Pharmacokinetics of Fluvastatin in Healthy Volunteers.
    Xiang Y, Okochi H, Kozachenko I, Sodhi JK, Frassetto LA, Benet LZ.
    Clin Pharmacol Ther; 2021 Aug 15; 110(2):480-485. PubMed ID: 33880760
    [Abstract] [Full Text] [Related]

  • 5. Liquid chromatography-tandem mass spectrometry method for the measurement of serum mevalonic acid: a novel marker of hydroxymethylglutaryl coenzyme A reductase inhibition by statins.
    Waldron J, Webster C.
    Ann Clin Biochem; 2011 May 15; 48(Pt 3):223-32. PubMed ID: 21355014
    [Abstract] [Full Text] [Related]

  • 6. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors.
    Lee CK, Choi JS, Choi DH.
    Pharmacol Rep; 2015 Feb 15; 67(1):44-51. PubMed ID: 25560574
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of Green Tea Extract on Atorvastatin Pharmacokinetics in Healthy Volunteers.
    Abdelkawy KS, Abdelaziz RM, Abdelmageed AM, Donia AM, El-Khodary NM.
    Eur J Drug Metab Pharmacokinet; 2020 Jun 15; 45(3):351-360. PubMed ID: 31997084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.
    Martin PD, Mitchell PD, Schneck DW.
    Br J Clin Pharmacol; 2002 Nov 15; 54(5):472-7. PubMed ID: 12445025
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery.
    El-Zailik A, Cheung LK, Wang Y, Sherman V, Chow DS.
    J Pharm Biomed Anal; 2019 Feb 05; 164():258-267. PubMed ID: 30396053
    [Abstract] [Full Text] [Related]

  • 12. Measurement of HMG CoA reductase activity in different human cell lines by ultra-performance liquid chromatography tandem mass spectrometry.
    Kuzaj P, Kuhn J, Faust I, Knabbe C, Hendig D.
    Biochem Biophys Res Commun; 2014 Jan 10; 443(2):641-5. PubMed ID: 24333427
    [Abstract] [Full Text] [Related]

  • 13. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR.
    Atherosclerosis; 1996 Jan 26; 119(2):203-13. PubMed ID: 8808497
    [Abstract] [Full Text] [Related]

  • 14. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P, Kafonek S, Laurora I, Hunninghake D.
    Am J Cardiol; 1998 Mar 01; 81(5):582-7. PubMed ID: 9514454
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.
    Hsyu PH, Schultz-Smith MD, Lillibridge JH, Lewis RH, Kerr BM.
    Antimicrob Agents Chemother; 2001 Dec 01; 45(12):3445-50. PubMed ID: 11709322
    [Abstract] [Full Text] [Related]

  • 16. New insights into the pharmacodynamic and pharmacokinetic properties of statins.
    Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F.
    Pharmacol Ther; 1999 Dec 01; 84(3):413-28. PubMed ID: 10665838
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic interaction between regorafenib and atorvastatin in rats.
    Szkutnik-Fiedler D, Szałek E, Otto F, Czyrski A, Karaźniewicz-Łada M, Wolc A, Grześkowiak E, Lewandowski K, Karbownik A.
    Pharmacol Rep; 2024 Oct 01; 76(5):1184-1195. PubMed ID: 38632186
    [Abstract] [Full Text] [Related]

  • 18. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
    Cilla DD, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL.
    Clin Pharmacol Ther; 1996 Dec 01; 60(6):687-95. PubMed ID: 8988072
    [Abstract] [Full Text] [Related]

  • 19. The pharmacokinetics of single-dose oral atorvastatin and its metabolites support therapeutic use in cockatiels (Nymphicus hollandicus).
    Mitchell M, Guzman DS, Knych H, Beaufrère H.
    Am J Vet Res; 2024 Jul 01; 85(7):. PubMed ID: 38626797
    [Abstract] [Full Text] [Related]

  • 20. Analysis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors using liquid chromatography-electrospray mass spectrometry.
    Park EJ, Lee D, Shin YG, Lantvit DD, van Breemen RB, Kinghorn AD, Pezzuto JM.
    J Chromatogr B Biomed Sci Appl; 2001 Apr 25; 754(2):327-32. PubMed ID: 11339276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.